Mycophenolate in scleroderma-associated interstitial lung disease: Real-world data from rheumatology and pulmonology clinics in South Asia.
Ramya JanardanaAparna IrodiPramod P ChebbiRuchika GoelLeena R VimalaShivraj PadiyarAnoof PeediyakalJohn MathewAswin NairDevasahayam J ChristopherDebashish DandaPublished in: Journal of scleroderma and related disorders (2021)
Mycophenolate mofetil/mycophenolate sodium was efficacious in improving /stabilizing forced vital capacity irrespective of the baseline high-resolution computed tomography lung scores in our patients with systemic sclerosis-related interstitial lung disease during the ⩾ 2-year follow-up period.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- computed tomography
- high resolution
- rheumatoid arthritis
- primary care
- idiopathic pulmonary fibrosis
- positron emission tomography
- magnetic resonance imaging
- electronic health record
- mass spectrometry
- machine learning
- systemic lupus erythematosus
- deep learning
- data analysis